Cogent Biosciences Inc Cash Flow Reinvestment Rate

Latest as of December 2015: 0.11x

Cogent Biosciences Inc cash flow reinvestment rate. Cogent Biosciences Inc (COGT) has a Cash Flow Reinvestment Rate of 0.11x as of December 2015, reinvesting $1.99 Million (capex $1.99 Million ) from operating cash flow of $17.72 Million. See Cogent Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

$1.99 Million
Capex + Investments

Operating Cash Flow

$17.72 Million
USD

Capital Expenditures

$1.99 Million
USD

Cash Flow Reinvestment Rate of Cogent Biosciences Inc (2015–2015)

Cash flow reinvestment rate of Cogent Biosciences Inc from 2015 to 2015. Historical reinvestment intensity for Cogent Biosciences Inc across 1 annual periods. Explore cash flow to debt ratio of Cogent Biosciences Inc to assess how comfortably operating cash covers total debt obligations.

Cogent Biosciences Inc Cash Flow Reinvestment Rate by Year (2015–2015)

Cogent Biosciences Inc cash flow reinvestment rate by year from 2015 to 2015. Year-by-year capital reinvestment analysis for Cogent Biosciences Inc. For the full cash flow conversion analysis, see COGT cash generation efficiency.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.11x $1.99 Million $17.72 Million $1.99 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow